These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10928575)

  • 1. Pramipexole-induced somnolence and episodes of daytime sleep.
    Hauser RA; Gauger L; Anderson WM; Zesiewicz TA
    Mov Disord; 2000 Jul; 15(4):658-63. PubMed ID: 10928575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group.
    Hobson DE; Lang AE; Martin WR; Razmy A; Rivest J; Fleming J
    JAMA; 2002 Jan 23-30; 287(4):455-63. PubMed ID: 11798367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole.
    Frucht S; Rogers JD; Greene PE; Gordon MF; Fahn S
    Neurology; 1999 Jun; 52(9):1908-10. PubMed ID: 10371546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.
    Etminan M; Samii A; Takkouche B; Rochon PA
    Drug Saf; 2001; 24(11):863-8. PubMed ID: 11665873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.
    Micallef J; Rey M; Eusebio A; Audebert C; Rouby F; Jouve E; Tardieu S; Blin O
    Br J Clin Pharmacol; 2009 Mar; 67(3):333-40. PubMed ID: 19220275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waking up to sleep episodes in Parkinson's disease.
    Olanow CW; Schapira AH; Roth T
    Mov Disord; 2000 Mar; 15(2):212-5. PubMed ID: 10752568
    [No Abstract]   [Full Text] [Related]  

  • 8. ["Sleep attacks" in Parkinson patients. A side effect of nonergoline dopamine agonists or a class effect of dopamine agonists?].
    Möller JC; Stiasny K; Cassel W; Peter JH; Krüger HP; Oertel WH
    Nervenarzt; 2000 Aug; 71(8):670-6. PubMed ID: 10996919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy.
    Pal S; Bhattacharya KF; Agapito C; Chaudhuri KR
    J Neural Transm (Vienna); 2001; 108(1):71-7. PubMed ID: 11261748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. Parkinson Study Group.
    JAMA; 1997 Jul; 278(2):125-30. PubMed ID: 9214527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
    Razmy A; Lang AE; Shapiro CM
    Arch Neurol; 2004 Jan; 61(1):97-102. PubMed ID: 14732626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study.
    Pinter MM; Pogarell O; Oertel WH
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):436-41. PubMed ID: 10201413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep episodes in Parkinson's disease: a wake-up call.
    Frucht SJ; Greene PE; Fahn S
    Mov Disord; 2000 Jul; 15(4):601-3. PubMed ID: 10928569
    [No Abstract]   [Full Text] [Related]  

  • 14. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group.
    Shannon KM; Bennett JP; Friedman JH
    Neurology; 1997 Sep; 49(3):724-8. PubMed ID: 9305331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.
    Dooley M; Markham A
    Drugs Aging; 1998 Jun; 12(6):495-514. PubMed ID: 9638397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil treatment of pramipexole-associated somnolence.
    Hauser RA; Wahba MN; Zesiewicz TA; McDowell Anderson W
    Mov Disord; 2000 Nov; 15(6):1269-71. PubMed ID: 11104221
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial.
    Möller JC; Oertel WH; Köster J; Pezzoli G; Provinciali L
    Mov Disord; 2005 May; 20(5):602-10. PubMed ID: 15726540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
    Parkinson Study Group
    JAMA; 2002 Apr; 287(13):1653-61. PubMed ID: 11926889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole and somnolence.
    Shuster J
    Nursing; 2000 Aug; 30(8):81. PubMed ID: 10983129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.